Farnesyltransferase inhibitors as radiation sensitizers.
Activation of Ras, by mutation, overexpression, or by signaling through tyrosine kinase receptors, is associated with radioresistance. Thus, therapies that inhibit Ras function could be an effective means to radiosensitize selected types of solid tumors. Inhibition of Ras prenylation using a variety...
Principais autores: | Mckenna, W, Muschel, R, Gupta, A, Hahn, S, Bernhard, E |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2002
|
Registros relacionados
-
Farnesyltransferase inhibitors as radiation sensitizers.
por: Brunner, T, et al.
Publicado em: (2003) -
Farnesyltransferase inhibitors as radiation sensitizers
por: Mckenna, W
Publicado em: (2005) -
Farnesyltransferase inhibitors.
por: Hahn, S, et al.
Publicado em: (2001) -
Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations.
por: Brunner, T, et al.
Publicado em: (2003) -
Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRAS.
por: Cohen-Jonathan, E, et al.
Publicado em: (2000)